Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: Commentary.
作者信息
Gastaldi Matteo, Franciotta Diego
机构信息
Neuroimmunology Laboratory and Neuroimmunology Research Unit, IRCCS Mondino Foundation National Neurological Institute, Pavia, Italy.
出版信息
Mult Scler. 2023 Jul;29(8):930-931. doi: 10.1177/13524585231172960. Epub 2023 May 25.
Abstract
摘要
相似文献
1
Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: Commentary.在视神经脊髓炎谱系疾病（MOGAD）的诊断和随访中，应常规检测血清MOG-IgG滴度：评论。
Mult Scler. 2023 Jul;29(8):930-931. doi: 10.1177/13524585231172960. Epub 2023 May 25.
2
Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: No.在MOGAD的诊断和随访中应常规检测血清MOG-IgG滴度：否。
Mult Scler. 2023 Jul;29(8):928-929. doi: 10.1177/13524585231172942. Epub 2023 May 25.
3
Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes.在MOGAD的诊断和随访中应常规检测血清MOG IgG滴度：是。
Mult Scler. 2023 Jul;29(8):926-927. doi: 10.1177/13524585231172954. Epub 2023 May 25.
4
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges.髓鞘少突胶质细胞糖蛋白抗体相关疾病（MOGAD）：现有认识与挑战。
J Neurol. 2023 Aug;270(8):4132-4150. doi: 10.1007/s00415-023-11737-8. Epub 2023 May 8.
5
[Diagnostic value of low versus high titers of MOG-IgG and their clinical implications in myelin oligodendrocyte glycoprotein antibody-associated disease: a retrospective singlecenter study].[低滴度与高滴度髓鞘少突胶质细胞糖蛋白免疫球蛋白G在髓鞘少突胶质细胞糖蛋白抗体相关疾病中的诊断价值及其临床意义：一项回顾性单中心研究]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Nov 20;43(11):1865-1873. doi: 10.12122/j.issn.1673-4254.2023.11.05.
6
Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.水通道蛋白-4 和髓鞘少突胶质细胞糖蛋白自身抗体状态预测复发性视神经炎的结局。
Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.
7
Longitudinal evaluation of serum MOG-IgG titers in MOGAD after initiation of maintenance immunoglobulin: A case series.MOGAD 患者开始维持性免疫球蛋白治疗后血清 MOG-IgG 滴度的纵向评估：一项病例系列研究。
Mult Scler. 2024 Apr;30(4-5):594-599. doi: 10.1177/13524585231211119. Epub 2023 Nov 29.
8
More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies.与抗髓鞘少突胶质细胞糖蛋白抗体相比，抗水通道蛋白 4 抗体更有效地激活补体。
Neurol Neuroimmunol Neuroinflamm. 2022 Nov 22;10(1). doi: 10.1212/NXI.0000000000200059. Print 2023 Jan.
9
Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.视神经炎治疗试验中患者的髓鞘少突胶质细胞糖蛋白和水通道蛋白4-IgG的患病率
JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.
10
Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.髓鞘少突胶质细胞糖蛋白免疫球蛋白 G（MOG-IgG）视神经炎的临床表型、影像学特征和治疗。
Curr Opin Neurol. 2020 Feb;33(1):47-54. doi: 10.1097/WCO.0000000000000766.
本文引用的文献
1
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.髓鞘少突胶质细胞糖蛋白抗体相关性疾病的诊断：国际 MOGAD 专家组提出的标准。
Lancet Neurol. 2023 Mar;22(3):268-282. doi: 10.1016/S1474-4422(22)00431-8. Epub 2023 Jan 24.
2
Humoral signatures of MOG-antibody-associated disease track with age and disease activity.MOG 抗体相关疾病的体液特征与年龄和疾病活动度相关。
Cell Rep Med. 2023 Feb 21;4(2):100913. doi: 10.1016/j.xcrm.2022.100913. Epub 2023 Jan 19.
3
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study.MOGAD 患者定量和纵向 MOG 抗体检测的预后相关性：一项多中心回顾性研究。
J Neurol Neurosurg Psychiatry. 2023 Mar;94(3):201-210. doi: 10.1136/jnnp-2022-330237. Epub 2022 Dec 2.
4
Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome.儿童获得性脱髓鞘综合征中 MOG 抗体的时间动态变化。
Neurol Neuroimmunol Neuroinflamm. 2022 Oct 13;9(6). doi: 10.1212/NXI.0000000000200035. Print 2022 Nov.
5
Using AChR antibody titres to predict treatment responses in myasthenia gravis.利用乙酰胆碱受体抗体滴度预测重症肌无力的治疗反应。
J Neurol Neurosurg Psychiatry. 2021 Sep;92(9):915. doi: 10.1136/jnnp-2021-326480. Epub 2021 May 7.
6
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.髓鞘少突胶质细胞糖蛋白自身抗体检测的阳性预测值。
JAMA Neurol. 2021 Jun 1;78(6):741-746. doi: 10.1001/jamaneurol.2021.0912.
7
Cell-based assays for the detection of MOG antibodies: a comparative study.用于检测髓鞘少突胶质细胞糖蛋白（MOG）抗体的细胞检测方法：一项比较研究。
J Neurol. 2020 Dec;267(12):3555-3564. doi: 10.1007/s00415-020-10024-0. Epub 2020 Jul 4.
8
International multicenter examination of MOG antibody assays.MOG 抗体检测的国际多中心研究。
Neurol Neuroimmunol Neuroinflamm. 2020 Feb 5;7(2). doi: 10.1212/NXI.0000000000000674. Print 2020 Mar 5.
9
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.MOG 细胞为基础的检测方法可用于诊断非 MS 炎性神经疾病患者。
Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89. doi: 10.1212/NXI.0000000000000089. eCollection 2015 Jun.
10
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.中枢神经系统脱髓鞘疾病中抗 MO-G 抗体的时间动态变化。
Clin Immunol. 2011 Mar;138(3):247-54. doi: 10.1016/j.clim.2010.11.013. Epub 2010 Dec 18.
Zotero 插件